Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

12.80

0.53 (4.32%)

At close: May 02, 2025, 3:59 PM

12.70

-0.78%

After-hours: May 02, 2025, 04:01 PM EDT

Cartesian Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	38.91M	26M	110.78M	85.08M	16.6M	6.68M	903K	207K	8.08M
Cost of Revenue	n/a	1.55M	2.04M	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	38.91M	24.45M	108.74M	85.08M	16.6M	6.68M	903K	207K	8.08M
Operating Income	-43.9M	-86.42M	14.54M	-4.6M	-56.82M	-52.45M	-65.02M	-63.78M	-34.67M
Interest Income	7.39M	n/a	n/a	n/a	n/a	834K	1.05M	617K	234K
Pretax Income	-77.14M	-238.71M	34.77M	-9.72M	-68.88M	-55.35M	-65.34M	-65.32M	-36.21M
Net Income	-77.42M	-219.71M	35.38M	-25.69M	-68.88M	-55.35M	-65.34M	-65.32M	-36.21M
Selling & General & Admin	30.13M	40.58M	23.86M	20.94M	18.91M	14.36M	17.26M	18.08M	12.25M
Research & Development	45.1M	71.84M	72.38M	68.74M	54.51M	42.74M	47.69M	45.16M	29.7M
Other Expenses	7.58M	n/a	330K	15K	89K	n/a	n/a	n/a	n/a
Operating Expenses	82.81M	110.87M	96.24M	89.67M	73.42M	57.1M	64.95M	63.24M	41.95M
Interest Expense	n/a	2.83M	3.03M	2.84M	1.56M	1.52M	1.49M	1.21M	1.25M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	82.81M	112.42M	96.24M	89.67M	73.42M	59.13M	65.92M	63.99M	42.75M
Income Tax Expense	287K	-19M	-609K	15.97M	1.65M	1.86M	1.00	n/a	n/a
Shares Outstanding (Basic)	17.28M	129.26M	120.63M	95.27M	84.34M	37.96M	18.66M	17.02M	8.74M
Shares Outstanding (Diluted)	17.28M	129.26M	121.56M	95.27M	84.34M	37.96M	18.66M	17.02M	8.74M
EPS (Basic)	-0.5	-49.76	7.20	-6.74	-20.42	-36.46	-87.55	-95.94	-103.52
EPS (Diluted)	-0.5	-49.76	3.00	-6.74	-20.42	-36.46	-87.55	-95.94	-103.52
EBITDA	-77.14M	-235.06M	39.84M	-5.16M	-65.59M	-51.8M	-62.87M	-63.37M	-34.16M
EBIT	-77.14M	-235.88M	37.8M	-6.88M	-67.32M	-53.83M	-63.84M	-64.11M	-34.96M
Depreciation & Amortization	n/a	843K	2.04M	1.72M	1.73M	2.03M	975K	750K	802K